Biomx INC 8-K filings

Tessera Defense and Homeland Security Inc. reported unregistered sales of equity securities and over $6 million raised through its at-the-market offering program.

Tessera Defense and Homeland Security Inc. has finalized an employment agreement with CEO Michael Oster, including performance-based equity incentives and a base salary, pending stockholder approval.

Tessera Defense and Homeland Security Inc. has entered into a new $5 million line of credit agreement with Mandragola Ltd., supplementing an existing credit facility.

Tessera Defense and Homeland Security Inc. announced its 2027 revenue target of $14-$16 million and long-term targets through 2029, projecting significant growth driven by its integrated physical security platform.

Tessera Defense and Homeland Security Israel Ltd. has entered into an option agreement to acquire 51% of RT LTA Systems Ltd., a developer of aerostat systems, with a purchase price contingent on RT's future financial performance.

Tessera Defense and Homeland Security Inc. has amended an agreement to increase its stake in M.E.A. Testing Systems Ltd. to 15% and secured a perpetual license for drone testing technologies.

Tessera Defense and Homeland Security Inc. (formerly BiomX Inc.) announced its rebranding and strategic focus on a unified security platform integrating AI, sensing, and response technologies.

BiomX Inc. announced a one-for-ten reverse stock split and a name change to Tessera Defense and Homeland Security Inc., effective September 9 and September 11, 2026, respectively.

BiomX Inc. files an amendment to its 8-K to clarify the treatment of fractional shares following its previously announced one-for-ten reverse stock split.

BiomX Inc. announced its corporate name change to Tessera Defense and Homeland Security Inc., effective September 11, 2026, with its stock to trade under the new ticker HLSQ.

BiomX Inc. is implementing a 1-for-10 reverse stock split to reduce its outstanding shares and comply with exchange listing requirements.

BiomX Inc. announced the overwhelming approval of several critical proposals by its stockholders at a Special Meeting, including a stock issuance for acquisition and a reverse stock split.

BiomX Inc. has entered into a Share Purchase and Option Agreement to acquire a 10% stake in M.E.A. Testing Systems Ltd., a developer of electric motor testing systems for drones, with an option for a controlling interest.

BiomX Inc. has amended a promissory note with Water IO Ltd., extending the maturity date and issuing restricted stock as consideration for accrued interest and payment delay.

BiomX Inc. has cancelled 1,013,637 restricted shares to regain compliance with NYSE American listing rules pending shareholder approval of a prior acquisition.

BiomX Inc. has dismissed Kesselman & Kesselman (PwC) as its independent auditor and engaged Barzily & Co. for the fiscal year ending December 31, 2026.

BiomX Inc. shareholders elected a director and approved an increase in shares for the 2026 Equity Incentive Plan.

BiomX Inc. announced an updated informational presentation detailing its strategic transition to a defense and security technology holding company, focusing on threat identification, analysis, and response.

BiomX Inc. has received approval from the NYSE American for a compliance plan to address stockholders' equity deficiencies, extending its listing deadline to September 25, 2027.

BiomX Inc. filed an amendment to its 8-K reports to provide audited financial statements and pro forma data for its recent acquisitions of Zorronet Ltd. and Dr. Frucht Systems Ltd.

BiomX Inc. has established a $2 million convertible credit line with Mandragola Ltd. and issued 2 million common stock warrants.

BiomX Inc. has appointed Roy Rousso as Chief Business Officer, effective July 1, 2026, under a part-time consulting arrangement.

BiomX Inc. announces a significant strategic transformation, discontinuing its legacy phage therapy programs and acquiring controlling interests in defense technology companies DFSL and Zorronet.

BiomX subsidiary Zorronet has signed a framework supply agreement with Israel Railways following a successful 98% success rate pilot program.

BiomX Inc. has acquired a controlling interest in DFSL, an Israeli defense company specializing in LADAR-based detection systems, to bolster its AI-enabled security capabilities.

BiomX Inc. announced that its stockholders overwhelmingly approved the 2026 Equity Incentive Plan at a special meeting held on April 10, 2026.

BiomX Inc. has completed the acquisition of ZorroNet, an Israeli AI defense technology company, for a combination of stock and a promissory note, establishing BiomX as an AI-powered defense technology platform.

BiomX Inc. has entered into an Option Agreement to acquire DR. Frucht Systems Ltd. (DFSL), a developer of LADAR-based anti-drone technology, for a mix of cash, convertible notes, preferred stock, and warrants.

BiomX Inc. received a notice from NYSE American regarding non-compliance with continued listing standards due to insufficient stockholders' equity and a going concern qualification.

BiomX Inc. announced an amendment to its warrants, significantly shortening their term and reducing the exercise price, alongside a strategic pivot towards defense-related applications and a focus on financial discipline.